Lund University Hosptial

Lund 22185

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma, Peripheral T-cell Lymphoma

Studies at this site

• A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma — Completed
• A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) — Completed